4-145081744-C-G
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The ENST00000507656.6(ANAPC10):āc.122G>Cā(p.Gly41Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000617 in 1,459,176 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: not found (cov: 33)
Exomes š: 0.0000062 ( 0 hom. )
Consequence
ANAPC10
ENST00000507656.6 missense
ENST00000507656.6 missense
Scores
14
3
2
Clinical Significance
Conservation
PhyloP100: 7.31
Genes affected
ANAPC10 (HGNC:24077): (anaphase promoting complex subunit 10) ANAPC10 is a core subunit of the anaphase-promoting complex (APC), or cyclosome, a ubiquitin protein ligase that is essential for progression through the cell cycle. APC initiates sister chromatid separation by ubiquitinating the anaphase inhibitor securin (PTTG1; MIM 604147) and triggers exit from mitosis by ubiquitinating cyclin B (CCNB1; MIM 123836), the activating subunit of cyclin-dependent kinase-1 (CDK1; MIM 116940) (summary by Wendt et al., 2001 [PubMed 11524682]).[supplied by OMIM, Feb 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.943
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANAPC10 | NM_001256706.2 | c.122G>C | p.Gly41Ala | missense_variant | 3/5 | ENST00000507656.6 | NP_001243635.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANAPC10 | ENST00000507656.6 | c.122G>C | p.Gly41Ala | missense_variant | 3/5 | 1 | NM_001256706.2 | ENSP00000423995 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD3 exomes AF: 0.00000804 AC: 2AN: 248908Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135048
GnomAD3 exomes
AF:
AC:
2
AN:
248908
Hom.:
AF XY:
AC XY:
1
AN XY:
135048
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000617 AC: 9AN: 1459176Hom.: 0 Cov.: 29 AF XY: 0.00000413 AC XY: 3AN XY: 725824
GnomAD4 exome
AF:
AC:
9
AN:
1459176
Hom.:
Cov.:
29
AF XY:
AC XY:
3
AN XY:
725824
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 26, 2022 | The c.122G>C (p.G41A) alteration is located in exon 3 (coding exon 2) of the ANAPC10 gene. This alteration results from a G to C substitution at nucleotide position 122, causing the glycine (G) at amino acid position 41 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;T;T;T;.;.;.;T;T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D;.;.;.;.;D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
M;M;M;M;.;.;.;.;.
MutationTaster
Benign
D;D;D;D
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
.;D;D;D;D;D;D;D;D
REVEL
Pathogenic
Sift
Pathogenic
.;D;D;D;D;D;D;D;D
Sift4G
Pathogenic
D;D;D;D;.;.;D;D;.
Polyphen
D;D;D;D;.;.;.;.;.
Vest4
MutPred
Loss of ubiquitination at K37 (P = 0.0699);Loss of ubiquitination at K37 (P = 0.0699);Loss of ubiquitination at K37 (P = 0.0699);Loss of ubiquitination at K37 (P = 0.0699);Loss of ubiquitination at K37 (P = 0.0699);Loss of ubiquitination at K37 (P = 0.0699);Loss of ubiquitination at K37 (P = 0.0699);Loss of ubiquitination at K37 (P = 0.0699);Loss of ubiquitination at K37 (P = 0.0699);
MVP
MPC
1.1
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at